Home | Welcome to Contract Pharma   
Last Updated Friday, November 28 2014
Print

Search Results for 'Financial Reports: Biogen Idec'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Can Multivariate Partnerships Streamline Drug Development?
Published June 3, 2014
Quintiles and Biogen Idec enter strategic pact aimed at optimizing Biogen’s clinical development processes Read More »
Published May 12, 2014
Rudick bring expertise in MS programs Read More »
Published April 10, 2014
Koppel to lead corporate strategy and portfolio management Read More »
Newsmakers: Jim Mullen
By James Mullen, Patheon
Published January 22, 2014
Patheon/DSM, industry trends, and more, with the CEO of Patheon Read More »
By Gil Roth
Published November 22, 2013
MS drug gets NAS designtation Read More »
Top 10 Biopharma Report
Published July 16, 2013
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace Read More »
Newsmakers: Jim Mullen
By Gil Y. Roth, Contract Pharma
Published May 4, 2012
Patheon's CEO talks about his first year on the job Read More »
Published February 6, 2012
Biogen assumes full development responsibilities and costs Read More »
By Gil Roth
Published January 6, 2014
Expects to begin trials of MS prodrug in mid-2014 Read More »
Picking Tomorrow’s Winners
By Peter Pollak and Andrew Badrot, CMS Pharma
Published October 9, 2013
Review the business development cycle in the custom manufacturing industry and assess risks associated with pharmaceutical fine chemicals manufacturing Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On